Novavax vaccine shows 51% efficacy against South African variant - study

The study also showed that prior infection with an earlier version of the virus did not reduce the risk of COVID-19 caused by the South African variant among people who got placebo shots

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020.

(photo credit: REUTERS/DADO RUVIC)

ByREUTERS

MAY 6, 2021 01:51

Novavax vaccine shows 51% efficacy against South African variant - study

The study also showed that prior infection with an earlier version of the virus did not reduce the risk of COVID-19 caused by the South African variant among people who got placebo shots

Where is there more protein: In fish, chicken, or red meat?

Weight-loss injections cause complications

Novavax vaccine shows 51% efficacy against South African variant - study

The study also showed that prior infection with an earlier version of the virus did not reduce the risk of COVID-19 caused by the South African variant among people who got placebo shots

See more on